Respiratory syncytial virus vaccine (Okairos)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRespiratory syncytial virus vaccine (Okairos)

Drug Alias NameMVA-RSV (ReiThera)PanAd3-RSVRSV-001

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesReithera Srl

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesReithera Srl

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A